Quarterly results round-up: Greatbatch revenue growth disguises poor Q1, PerkinElmer raises earnings guidance
This article was originally published in Clinica
Executive Summary
Implantable medical device specialist Greatbatch grew its revenues by 7% in its first fiscal quarter, primarily through its acquired businesses. On an organic constant currency basis, sales were down 6%. The firm's net income also dropped to $4.5m, versus $11.9m during last year's Q1.